(852) 2960 2388



Biotechnology industry has been the main target since Chinese government’s previous plan, 12th FYP, where 1.7 trillion was injected into this industry. With the goal of doubling the industry’s scale through scaling up of a new generation of biotechnology products and services in its recent 13th FYP, China’s pharma innovation continues to spur through strong state support.